Ehsan Irajizad

Aug 23, 2024 | digitalcommons.library.tmc.edu | Xiaotao Zhang |Ehsan Irajizad |Kristi Hoffman |Johannes F Fahrmann

BACKGROUND: Accessible prebiotic foods hold strong potential to jointly target gut health and metabolic health in high-risk patients. The BE GONE trial targeted the gut microbiota of obese surveillance patients with a history of colorectal neoplasia through a straightforward bean intervention. METHODS: This low-risk, non-invasive dietary intervention trial was conducted at MD Anderson Cancer Center (Houston, TX, USA).